Lucerne
Switzerland
8
2025-01-30
4
2026-02-10
These are the the leading inventors for applications assigned to MSD International GMBH:
MSD International GMBH based in Lucerne, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
C-TERMINAL EXTENDED P53 ACTIVATOR CROSSLINKED PEPTIDOMIMETIC MACROCYCLES AGAINST MDM2/MDMX
#2 | 2024-03-14 ✅ Patent 12,544,888 granted on 2026-02-10GENDERLESS INTERFACE CONNECTOR PULL TOOL
#3 | 2023-01-26METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE
#4 | 2022-12-29COMBINATION OF A PD-1 ANTAGONIST, A VEGFR/FGFR/RET TYROSINE KINASE INHIBITOR AND A CBP/BETA-CATENIN INHIBITOR FOR TREATING CANCER
#5 | 2022-11-17 ✅ Patent 12,173,026 granted on 2024-12-24PRMT5 inhibitors
#6 | 2022-02-10CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
#7 | 2021-10-28 ✅ Patent 11,883,479 granted on 2024-01-30Method for treating cervical cancer
#8 | 2021-07-08 ✅ Patent 11,730,748 granted on 2023-08-22Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases
Also check out MSD International GMBH's (Lucerne, Switzerland) applicant profile with 12 patent applications submitted.
312424 ⎘